Health UnaBASHEd: Risk, Resilience, and the Future of Medicine with Michael Rosenblatt, MD

On this episode Gil sits with Michael Rosenblatt, MD, one of the most accomplished physician-scientists in modern medicine. He is former Chief Medical Officer of Merck, where he led global scientific strategy and medical affairs. Previously he served as Dean of Tufts University School of Medicine, Chief Scientific Officer at Vertex Pharmaceuticals, and Professor of Medicine at Harvard Medical School, where he advanced groundbreaking research in endocrinology, metabolic bone disease, and translational science. We discuss the intersection of academia, biotechnology, pharmaceutical innovation, and the clinical science shaping modern drug development and the future of precision therapeutics.